Targeting microparticle biogenesis: A novel approach to the circumvention of cancer multidrug resistance

Current Cancer Drug Targets

Volumn 15, Issue 3, 2015, Pages 205-214

  Roseblade, Ariane ^a   Luk, Frederick ^a   Ung, Alison ^a   Bebawy, Mary ^a  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

Calcium channel blockers; Calpain; Cancer; Microparticle inhibitors; Microparticles; Microvesicles; Multidrug resistance; Rho associated kinase (ROCK)

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL) CYCLOHEXANECARBOXAMIDE; CALCIMYCIN; CALPAIN; CALPASTATIN; CYSTAMINE; DOXORUBICIN; LIPOCORTIN 5; MERCAPTAMINE; PANTETHINE; PANTOTHENIC ACID; PD 150606; RHO KINASE INHIBITOR; UNCLASSIFIED DRUG; VERAPAMIL; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ACRYLIC ACID DERIVATIVE; AMIDE; ANTINEOPLASTIC AGENT; N-ACETYLLEUCYL-LEUCYL-METHIONINAL; OLIGOPEPTIDE; PANTETHEINE; PYRIDINE DERIVATIVE;

ARTICLE; BIOGENESIS; CALCIUM CELL LEVEL; CANCER CELL CULTURE; CANCER PREVENTION; CELL ACTIVATION; CELL VIABILITY; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG SENSITIVITY; DRUG TARGETING; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MCF 7 CELL LINE; MEMBRANE MICROPARTICLE; MULTIDRUG RESISTANCE; NEOPLASM; TRYPAN BLUE ASSAY; ANALOGS AND DERIVATIVES; BREAST NEOPLASMS; DRUG EFFECTS; DRUG RESISTANCE; FEMALE; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOLOGY; PROCEDURES; TUMOR CELL LINE;

ACRYLATES; AMIDES; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CALCIMYCIN; CELL LINE, TUMOR; CELL-DERIVED MICROPARTICLES; CYSTAMINE; CYSTEAMINE; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MOLECULAR TARGETED THERAPY; OLIGOPEPTIDES; PANTETHEINE; PYRIDINES; VERAPAMIL;

EID: 84929271518     PISSN: 15680096     EISSN: 18735576     Source Type: Journal    
DOI: 10.2174/1568009615666150225121508     Document Type: Article

References (49)

1. Longley, D.; Johnston, P. Molecular mechanisms of drug resistance. J. Pathol., 2005, 205(2), 275-292.
2. Biedler, J.L.; Riehm, H. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. Cancer Res., 1970, 30(4), 1174-1184.
3. Gong, J.; Jaiswal, R.; Mathys, J.M.; Combes, V.; Grau, G.; Bebawy, M. Microparticles and their emerging role in cancer multidrug resistance. Cancer Treat. Rev., 2012, 38(3), 226-234.
4. Bebawy, M.; Morris, M.; Roufogalis, B. Selective modulation of P- glycoprotein-mediated drug resistance. Br. J. Cancer, 2001, 85(12), 1998.
5. Zaman, G.; Flens, M.; Van Leusden, M.; De Haas, M.; Mülder, H.; Lankelma, J.; Pinedo, H.; Scheper, R.; Baas, F.; Broxterman, H. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc. Natl. Acad. Sci. U. S. A., 1994, 91(19), 8822-8826.
6. Breuninger, L.M.; Paul, S.; Gaughan, K.; Miki, T.; Chan, A.; Aaronson, S.A.; Kruh, G.D. Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. Cancer Res., 1995, 55(22), 5342-5347.
7. Chan, H.S.L.; Thorner, P.S.; Haddad, G.; Ling, V. Immuno- histochemical detection of P-glycoprotein: Prognostic correlation in soft tissue sarcoma of childhood. J. Clin. Oncol., 1990, 8(4), 689-704.
8. Bebawy, M.; Combes, V.; Lee, E.; Jaiswal, R.; Gong, J.; Bonhoure, A.; Grau, G.E. Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells. Leukemia, 2009, 23(9), 1643-1649.
9. Gyorgy, B.; Szabo, T.G.; Pasztoi, M.; Pal, Z.; Misjak, P.; Aradi, B.; Laszlo, V.; Pallinger, E.; Pap, E.; Kittel, A.; Nagy, G.; Falus, A.; Buzas, E.I. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol. Life Sci., 2011, 68(16), 2667-2688.
10. Morel, O.; Jesel, L.; Freyssinet, J.M.; Toti, F. Cellular mechanisms underlying the formation of circulating microparticles. Arterioscler. Thromb. Vasc. Biol., 2011, 31(1), 15-26.
11. Comfurius, P.; Senden, J.M.G.; Tilly, R.H.J.; Schroit, A.J.; Bevers, E.M.; Zwaal, R.F.A. Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase. Biochim. Biophys. Acta., 1990, 1026(2), 153-160.
12. Campbell, L.E.; Nelson, J.; Gibbons, E.; Judd, A.M.; Bell, J.D. Membrane properties involved in calcium-stimulated microparticle release from the plasma membranes of S49 lymphoma cells. The Scientific World Journal, 2014, 2014, 537192.
13. Gutiérrez-Vázquez, C.; Villarroya-Beltri, C.; Mittelbrunn, M.; Sánchez-Madrid, F. Transfer of extracellular vesicles during immune cell‐cell interactions. Immunol. Rev., 2013, 251(1), 125-142.
14. Fox, J.; Austin, C.; Reynolds, C.; Steffen, P. Evidence that agonist-induced activation of calpain causes the shedding of procoagulant-containing microvesicles from the membrane of aggregating platelets. J. Biol. Chem., 1991, 266(20), 13289-13295.
15. Latham, S.L.; Chaponnier, C.; Dugina, V.; Couraud, P.-O.; Grau, G.E.; Combes, V. Cooperation between β-and γ-cytoplasmic actins in the mechanical regulation of endothelial microparticle formation. FASEB J., 2013, 27(2), 672-683.
16. Li, B.; Antonyak, M.; Zhang, J.; Cerione, R. RhoA triggers a specific signaling pathway that generates transforming microvesicles in cancer cells. Oncogene, 2012, 31(45), 4740-4749.
17. Jaiswal, R.; Luk, F.; Dalla, P.V.; Grau, G.E.R.; Bebawy, M. Breast cancer-derived microparticles display tissue selectivity in the transfer of resistance proteins to cells. PLoS One, 2013, 8(4), e61515.
18. Jaiswal, R.; Luk, F.; Gong, J.; Mathys, J.M.; Grau, G.E.R.; Bebawy, M. Microparticle conferred microRNA profiles-implications in the transfer and dominance of cancer traits. Mol. Cancer, 2012, 11(1), 37.
19. Lu, J.F.; Luk, F.; Gong, J.; Jaiswal, R.; Grau, G.E.; Bebawy, M. Microparticles mediate MRP1 intercellular transfer and the re-templating of intrinsic resistance pathways. Pharmacol. Res., 2013, 76, 77-83.
20. Jaiswal, R.; Gong, J.; Sambasivam, S.; Combes, V.; Mathys, J.-M.; Davey, R.; Grau, G.E.; Bebawy, M. Microparticle-associated nucleic acids mediate trait dominance in cancer. FASEB J., 2012, 26(1), 420-429.
21. Gong, J.; Luk, F.; Jaiswal, R.; Bebawy, M. Microparticles mediate the intercellular regulation of microRNA-503 and proline-rich tyrosine kinase 2 to alter the migration and invasion capacity of breast cancer cells. Front. Oncol., 2014, 4, 220.
22. Gong, J.; Luk, F.; Jaiswal, R.; George, A.M.; Grau, G.E.R.; Bebawy, M. Microparticle drug sequestration provides a parallel pathway in the acquisition of cancer drug resistance. Eur. J. Pharmacol., 2013, 721(1), 116-125.
23. Roseblade, A.; Luk, F.; Rawling, T.; Ung, A.; Grau, G.E.; Bebawy, M. Cell-Derived microparticles: New targets in the therapeutic management of disease. J. Pharm. Pharm. Sci., 2013, 16(2), 238-253.
24. Kars, M.D.; Iseri, O.D.; Gunduz, U.; Ural, A.U.; Arpaci, F.; Molnar, J. Development of rational in vitro models for drug resistance in breast cancer and modulation of MDR by selected compounds. Anticancer Res., 2006, 26(6B), 4559-4568.
25. Fox, J.; Austin, C.D.; Boyles, J.K.; Steffen, P.K. Role of the membrane skeleton in preventing the shedding of procoagulant-rich microvesicles from the platelet plasma membrane. J. Cell Biol., 1990, 111(2), 483-493.
26. Pasquet, J.M.; DacharyPrigent, J.; Nurden, A.T. Calcium influx is a determining factor of calpain activation and microparticle formation in platelets. Eur. J. Biochem., 1996, 239(3), 647-654.
27. Combes, V.; Simon, A.C.; Grau, G.E.; Arnoux, D.; Camoin, L.; Sabatier, F.; Mutin, M.; Sanmarco, M.; Sampol, J.; DignatGeorge, F. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J. Clin. Invest., 1999, 104(1), 93-102.
28. Chen, J.S.; Konopleva, M.; Andreeff, M.; Multani, A.S.; Pathak, S.; Mehta, K. Drug‐resistant breast carcinoma (MCF‐7) cells are paradoxically sensitive to apoptosis. J. Cell. Physiol., 2004, 200(2), 223-234.
29. Connor, D.E.; Exner, T.; Ma, D. D. F.; Joseph, J.E. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib. Thromb. Haemost., 2010, 103(5), 1044-1052.
30. Jimenez, J.J.; Jy, W.; Mauro, L.M.; Soderland, C.; Horstman, L.L.; Ahn, Y.S. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thrombosis Res. 2003, 109(4), 175-180.
31. Wu, M.; Yu, Z.; Fan, J.; Caron, A.; Whiteway, M.; Shen, S.-H. Functional dissection of human protease µ-calpain in cell migration using RNAi. FEBS Lett., 2006, 580(13), 3246-3256.
32. Chakraborti, S.; Alam, M.N.; Paik, D.; Shaikh, S.; Chakraborti, T. Implications of calpains in health and diseases. Indian J. Biochem. Biophys., 2012, 49(5), 316-328.
33. Bassé, F.; Gaffet, P.; Bienvenüe, A. Correlation between inhibition of cytoskeleton proteolysis and anti-vesiculation effect of calpeptin during A23187-induced activation of human platelets: are vesicles shed by filopod fragmentation? Biochim. Biophys. Acta., 1994, 1190(2), 217-224.
34. Goll, D.E.; Thompson, V.F.; Li, H.; Wei, W.; Cong, J. The calpain system. Physiol. Rev., 2003, 83(3), 731-801.
35. Pottle, J.; Sun, C.; Gray, L.; Li, M. Exploiting MCF-7 cells’ calcium dependence with interlaced therapy. J. Cancer Ther., 2013, 4(07), 32-40.
36. Dachary-Prigent, J.; Freyssinet, J.-M.; Pasquet, J.-M.; Carron, J.-C.; Nurden, A. T. Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups. Blood, 1993, 81(10), 2554-2565.
37. Amano, M.; Ito, M.; Kimura, K.; Fukata, Y.; Chihara, K.; Nakano, T.; Matsuura, Y.; Kaibuchi, K. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J. Biol. Chem., 1996, 271(34), 20246-20249.
38. Coleman, M.L.; Sahai, E.A.; Yeo, M.; Bosch, M.; Dewar, A.; Olson, M.F. Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat. Cell. Biol., 2001, 3(4), 339-345.
39. Sapet, C.; Simoncini, S.; Loriod, B.; Puthier, D.; Sampol, J.; Nguyen, C.; Dignat-George, F.; Anfosso, F. Thrombin-induced endothelial microparticle generation: identification of a novel pathway involving ROCK-II activation by caspase-2. Blood, 2006, 108(6), 1868-1876.
40. Abid Hussein, M.N.; Boing, A.N.; Sturk, A.; Hau, C.M.; Nieuwland, R. Inhibition of microparticle release triggers endothelial cell apoptosis and detachment. Thromb. Haemost., 2007, 98(5), 1096-1107.
41. Böing, A.; Stap, J.; Hau, C.; Afink, G.; Ris-Stalpers, C.; Reits, E.; Sturk, A.; van Noorden, C.; Nieuwland, R. Active caspase-3 is removed from cells by release of caspase-3-enriched vesicles. Biochim. Biophys. Acta, 2013, 1833(8), 1844-1852.
42. Yang, S.; Kim, H.-M. ROCK inhibition activates MCF-7 cells. PloS One, 2014, 9(2), e88489.
43. Taylor, J.; Simpson, R. Inhibition of cancer cell growth by calcium channel antagonists in the athymic mouse. Cancer Res., 1992, 52(9), 2413-2418.
44. Nomura, S.; Inami, N.; Kimura, Y.; Omoto, S.; Shouzu, A.; Nishikawa, M.; Iwasaka, T. Effect of nifedipine on adiponectin in hypertensive patients with type 2 diabetes mellitus. J. Hum. Hypertens., 2006, 21(1), 38-44.
45. Bertolesi, G.E.; Shi, C.; Elbaum, L.; Jollimore, C.; Rozenberg, G.; Barnes, S.; Kelly, M.E. The Ca2+ channel antagonists mibefradil and pimozide inhibit cell growth via different cytotoxic mechanisms. Mol. Pharmacol., 2002, 62(2), 210-219.
46. Horváth, Z.; Vécsei, L. Current medical aspects of pantethine. Ideggyogy Sz., 2009, 62(7-8), 220-229.
47. Penet, M.F.; Abou-Hamdan, M.; Coltel, N.; Cornille, E.; Grau, G.E.; De Reggi, M.; Gharib, B. Protection against cerebral malaria by the low-molecular-weight thiol pantethine. Proc. Natl. Acad. Sci. U. S. A., 2008, 105(4), 1321-1326.
48. Fujisawa, T.; Rubin, B.; Suzuki, A.; Patel, P.S.; Gahl, W.A.; Joshi, B.H.; Puri, R.K. Cysteamine suppresses invasion, metastasis and prolongs survival by inhibiting matrix metalloproteinases in a mouse model of human pancreatic cancer. PloS One, 2012, 7(4), e34437.
49. Jeitner, T.M.; Delikatny, E.J.; Bartier, W.A.; Capper, H.R.; Hunt, N.H. Inhibition of drug-naive and -resistant leukemia Cell proliferation by low molecular weight thiols. Biochem. Pharmacol., 1998, 55(6), 793-802.